Gluten Challenge

RESEARCH TRIANGLE PARK, N.C., September 2, 2026 Opus Genetics, Inc. plans to present topline clinical data from Cohort 1...

TEL AVIV, Israel, September 2, 2026 Teva Pharmaceutical Industries Ltd. has reported positive topline results from its ongoing Phase...